Scandinavian journal of gastroenterology
-
Scand. J. Gastroenterol. · Oct 2007
Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.
The assessment of intestinal inflammation in patients with inflammatory bowel disease (IBD) remains a difficult challenge. Both rectal nitric oxide (NO) and fecal calprotectin can be measured using non-invasive methods and are emerging as promising inflammatory markers in IBD. In this study the aim was to compare calprotectin and NO levels in IBD patients. ⋯ Both rectal NO and fecal calprotectin are greatly increased during bowel inflammation, but they may reflect different parts of the inflammatory process. Future studies will elucidate the clinical usefulness of these two markers.
-
Scand. J. Gastroenterol. · Sep 2007
Case ReportsSuccessful resection of a giant recurrent gastrointestinal stromal tumour with imatinib mesylate as neoadjuvant therapy.
Gastrointestinal stromal tumours (GISTs) are the most common mesenchymal tumours of the GI tract. Although a great deal of experience has been obtained with imatinib mesylate in patients with unresectable or metastatic GISTs, its role in the neoadjuvant setting is not well established. In this paper, we describe a case of successful resection of a giant recurrent GIST with imatinib mesylate as neoadjuvant therapy.
-
Despite laparoscopic cholecystectomy being the preferred treatment for elective cholecystectomy, surgery for acute cholecystitis is often performed using the open method. The aim of the study was to assess the incidence of cholecystectomy for acute cholecystitis and to determine the proportion of laparoscopically completed procedures compared with all cholecystectomies for acute cholecystitis. ⋯ The total number of patients having cholecystectomy for acute cholecystitis has increased as has the rate of laparoscopically completed procedures. It is not known whether it is possible to obtain a further reduction in the number of open cholecystectomies.
-
Scand. J. Gastroenterol. · May 2007
Letter Case ReportsTerlipressin causing a hyponatraemic seizure.